CellAdvantage® - CBR's Superior Collection
& Processing System
FDA Cleared Processing Technology
CBR's CellAdvantage® system is the only FDA-cleared automated cord blood processing system, AutoXpress™ Platform (AXP™), that can process any collection regardless of volume. AXP has the highest cell recovery rate in the industry (99%), which is critical since the goal and value of your investment in family banking is to save as many cells as possible for your family. If the cells are needed, a higher volume of cells can result in improved treatment success.
The charts below illustrate CBR’s superior cell recovery rates:
Learn about our secure, state-of the art storage facility.
Read more
Take Virtual Tour 
Proven Sterile Collection System
After your baby is born, your doctor will collect the cord blood using a syringe or gravity bag. With the syringe, the collection is similar to drawing blood for a blood test, while the bag uses gravity to collect the cord blood. The procedure usually takes less than 5 minutes.
CBR's collection methods are FDA compliant and designed to ensure your doctor is able to collect as much cord blood as possible. We use collection systems that are 100% sterile and we are OSHA - (Occupational Safety and Health Administration) compliant to meet all hospital safety and regulatory guidelines.
Watch a cord blood collection
References:
- AXP Data on File, CBR Systems, Inc.
- Kurtzberg J, Cairo MS,
Fraser JK, et al. Results of the Cord Blood Transplantation (COBLT) Study
unrelated donor banking program. Transfusion. 2005;45:842-855.
- Lapierre
V, Pellegrini N, Bardey I, et al. Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyethyl startch sedimentation) for routine cord blood banking: a comparative study.Cytotherapy. 2007;9:165-169.
- Papasssavas AC,
Goika V, Chatzistamatiou T, et al. A strategy of splitting individual high volume cord blood units into two half subunits prior to processing increases the recovery of cells and facilitates ex vivo expansion of the infused haematopoietic progenitor cells in adults. Int Jnl Lab Hem. 2007;1-9.
© Cbr Systems Inc. 1007 MA01382.00
In addition to the current uses, new medical applications for cord blood
stem cells are being discovered rapidly; however, banking cord blood does
not guarantee that the cells will provide a cure or be applicable for every
situation.
ThermoGenesis,® AutoXpress, and AXP_are registered trademarks of
ThermoGenesis Corp.
Sepax is a registered trademark of Biosafe SA.
Viacord is a registered trademark of ViaCell, Inc.
Cryo-Cell® is a registered trademark of Cryo-Cell International, Inc.
|
